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Heme oxygenase-1 (HO-1) catalyzes the rate-limiting step in
heme degradation, producing equimolar amounts of carbon
monoxide, iron, and biliverdin. Induction of HO-1 is a
beneficial response to tissue injury in diverse animal models
of diseases including acute kidney injury. In vitro analysis
has shown that the human HO-1 gene is transcriptionally
regulated by changes in chromatin conformation, but
whether such control occurs in vivo is not known. To enable
such an analysis, we generated transgenic mice, harboring
an 87-kb bacterial artificial chromosome expressing human
HO-1 mRNA and protein and bred these mice with HO-1
knockout mice to generate humanized BAC transgenic mice.
This successfully rescued the phenotype of the knockout
mice including reduced birth rates, tissue iron overload,
splenomegaly, anemia, leukocytosis, dendritic cell
abnormalities, and survival after acute kidney injury induced
by rhabdomyolysis or cisplatin nephrotoxicity. Transcription
factors such as USF1/2, JunB, Sp1, and CTCF were found to
associate with regulatory regions of the human HO-1 gene
in the kidney following rhabdomyolysis. Chromosome
conformation capture and ChIP-loop assays confirmed this
in the formation of chromatin looping in vivo. Thus, these
bacterial artificial chromosome humanized HO-1 mice are a
valuable model to study the human HO-1 gene, providing
insight to the in vivo architecture of the gene in acute kidney
injury and other diseases.
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Heme oxygenase (HO) is an enzyme that catalyzes the initial
and rate-limiting reaction in heme catabolism, resulting in
the production of carbon monoxide, iron, and biliverdin.1–3
Two isoforms of heme oxygenase have been characterized: an
inducible enzyme, HO-1, and a constitutive isoform, HO-2.
A third catalytically inactive isoform, HO-3, has been
described but is suggested to be a pseudogene.4 Besides its
function in heme degradation and iron reutilization,5,6 HO-1
exhibits potent cytoprotective effects via anti-inflammatory,
anti-apoptotic, and anti-oxidant properties of its reaction
products.6,7 Because of the beneficial roles of HO-1 in various
disease states including renal injury from ischemia–reperfu-
sion injury,8,9 glomerulonephritis,10,11 nephrotoxins,12 renal
transplant rejection,13–15 and rhabdomyolysis,16,17 a large
number of studies have explored the mechanisms of HO-1
transcription, translation, and its multiple functions using
in vitro and in vivo model systems. Among them, a global
HO-1 knockout mouse (HO-1–/–) has been used widely
as a model for studying the functions of HO-1 in vivo.5,18
HO-1–/– mice show several phenotypical alterations including
reduced live birth rates, tissue iron deposition, splenomegaly,
increased sensitivity to oxidative stress and acute kidney
injury, anemia, and leukocytosis.5,18
There have been studies using mouse models overexpressing
HO-1 generated with cDNA constructs.19–25 Organ-specific
HO-1-overexpressing mice were generated to study the
protective functions of HO-1 in cardiac diseases,22 and
global HO-1-overexpressing rats have also been character-
ized.23 Gene delivery via viral vectors to transfer the HO-1
gene has been tested in animal models.26 However, despite
the fact that the main function of HO-1, heme degradation
and cytoprotection, is the same in both humans and rodents,
it is difficult to utilize these models for mechanistic analysis
of the human HO-1 gene because of major differences
between the molecular regulation of the mouse and human
HO-1 genes.27 For instance, the human HO-1 gene contains a
potential cadmium response element, which has been iden-
tified at 4.0 kb of the 50 flanking region of the HO-1
gene.28,29 However, the cadmium response element in the
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mouse HO-1 gene is immediately 30 to this region, and is a
nuclear factor (erythroid-derived 2)–like 2 sequence.30 Heat
shock and cytokines such as interferon-g and hypoxia are
potent inducers of HO-1 in rodent cells, but repress HO-1
expression in human cells.28,31,32 Moreover, a 220-bp intronic
enhancer that we recently identified in the human HO-1
gene33,34 is not present in the mouse HO-1 gene. Therefore,
generating a relevant in vivo model is a fundamental
prerequisite to study human HO-1 regulation and expression.
We have shown that multiple regulatory regions within
the HO-1 gene interact with each other via chromatin
looping and a transcription factor, specificity protein 1 (Sp1),
mediates changes in chromatin conformation and initiation
of human HO-1 transcription in renal epithelial cells
in vitro.33 Both positive and negative regulatory sequences
in the human HO-1 promoter that bind to specific
transcription factors have been described to control HO-1
gene transcription in vitro. For example, JunB and upstream
stimulatory factors 1 and (USF1/2) activate HO-1 gene
expression, whereas JunD acts as a repressor.35,36 In order to
investigate these findings including changes in chromosome
conformation and associated transcription factors in vivo, an
animal model of the human HO-1 gene along with critical
regulatory regions was developed. HO-1 bacterial artificial
chromosome (BAC) mice were used to generate ‘humanized’
HO-1 (hHO-1) BAC mice containing the human HO-1 gene
but not the mouse HO-1 gene and studied in rhabdomyolysis
and cisplatin models of acute kidney injury in vivo.
RESULTS
Generation of HO-1 BAC transgenic mice
HO-1 BAC transgenic mice were generated by microinjection
of purified BAC DNA containing the human HO-1 gene
(GenBank accession number: Z82244) depicted in Figure 1a
into C57BL/6 oocytes. Two founders were obtained and
genotyped by PCR using four primer pairs that amplify
different regions within the BAC DNA (Table 1). As shown in
Figure 1b, both founders carried the transgene and the copy
number of the transgene was estimated by Taqman real-time
PCR as described in the Materials and Methods. Estimated
copy number of the two founders was 3 to 6. However, after
the third generation (F3), copy number of all transgenic mice
was between 1 and 2. Southern blot analysis on tail genomic
DNA digested with EcoRI and probed with a 320-bp fragment
within the HO-1 gene revealed a single band at 8 kb (Figure
1c). Fluorescence in situ hybridization (FISH) analysis using
HO-1 BAC as a probe showed a single integration site in
peripheral blood (Figure 1d, right panel) and bone marrow
cells (Figure 1e). Sequential metaphase FISH analysis
localized the site of integration into chromosome 5 band
qF (Figure 1e).
Characterization of HO-1 BAC transgenic mice
Monitoring body weight (Figure 2a) and blood pressure
(data not shown) in the HO-1 BAC transgenic mice showed
no significant differences compared with HO-1þ /þ mice.
Furthermore, no difference in terms of growth, development,
and survival were noted between HO-1 BAC compared with
HO-1þ /þ mice. Tissues from HO-1 BAC transgenic and
HO-1þ /þ mice were tested for HO-1 mRNA and protein
expression. HO-1 mRNA levels were significantly higher
(15–40-fold) in the heart, lung, liver, spleen, and kidney
of the HO-1 BAC transgenic mice compared with the
HO-1þ /þ tissues (Figure 2b). HO enzyme activity in tissues
from HO-1 BAC mice was also increased compared with
HO-1þ /þ mice (Figure 2c). In addition, HO-1 protein was
overexpressed (2–3-fold higher) in aorta, brain, heart, lung,
liver, spleen, intestine, skin, and kidney of HO-1 BAC
transgenic mice compared with tissues from HO-1þ /þ mice
(Figure 2d). HO-2 levels in the HO-1 BAC mice were similar
to HO-1þ /þ mice (Figure 2d). These results indicate that
HO-1 mRNA and protein are globally overexpressed in HO-1
BAC transgenic mice in the basal state and associated with
increased HO enzyme activity, indicating that the over-
expressed HO-1 protein in HO-1 BAC transgenic mice was
functionally active.
To examine the localization of HO-1 expression in HO-1
BAC transgenic mice, immunohistochemistry was performed
(Figure 2e). As expected, higher levels of HO-1 expression
were observed in tissues (brain, heart, lung, liver, spleen, and
kidney) of HO-1 BAC transgenic mice compared with HO-
1þ /þ mice. The expected high basal HO-1 expression in the
spleen was even higher in the HO-1 BAC transgenic mice.
The staining pattern in the kidney showed the presence of
HO-1 predominantly in renal proximal tubules, which was
confirmed by colocalization with lotus lectin (Figure 2f).
Generation and characterization of humanized HO-1 BAC
transgenic mice
Although the HO-1 BAC mice showed global overexpression
of HO-1, the endogenous mouse HO-1 gene is still intact in
these mice. To overcome this limitation, HO-1 BAC mice
were bred with HO-1/ mice. Because of low number of live
births from female HO-1/ mice, we initially crossed
female HO-1 BAC mice with male HO-1/ mice to obtain
HO-1þ / mice, which would carry the human HO-1 BAC
transgene (BAC positive and HO-1þ /). Then, these HO-1þ /
BAC-positive mice were crossed with each other to obtain
HO-1/ mice expressing only the human HO-1 gene (BAC
positive and HO-1/). The initial hHO-1 BAC transgenic
mice were genotyped by using two primers that were used for
genotyping HO-1 BAC transgenic mice (primers a and b,
Table 1) and mouse HO-1 primers to confirm that the
transgenic mice are indeed both BAC positive and mouse
HO-1 negative (Figure 3a). Among five transgenic mice,
three were HO-1 BAC positive (hHO-1 BAC 101, 104, and
105) and three were mouse-specific HO-1/ for the mouse
gene (hHO-1 BAC 103, 104, and 105). Thus, hHO-1 BAC 104
and 105 were determined to be both mouse-specific HO-1/
and HO-1 BAC positive and referred to as hHO-1 BAC.
Using species-specific primers as listed in Table 1, further
generations were genotyped to confirm the presence of
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Figure 1 |Generation of heme oxygenase-1 (HO-1) bacterial artificial chromosome (BAC) transgenic mice. (a) Schematic of B87 kb
human BAC DNA (GenBank accession number: Z82244), a portion of human chromosome 22, containing the HO-1 gene along with the 30
end of TOM1, and MCM5 genes used for the generation of HO-1 BAC mice is shown. a, b, c, and d represent the amplicons that were used to
genotype the HO-1 BAC transgenic mice. Sequences of primers are listed in Table 1. (b) Four primer pairs were used to amplify regions
a–d by PCR for genotyping the HO-1 BAC transgenic mice using tail DNA. DNA from wild-type C57BL6/J was used as a negative control
(HO-1þ /þ ). Positive control was purified HO-1 BAC DNA used for the generation of HO-1 BAC transgenic mice. (c) Founder mice were
identified by Southern blot analysis of tail DNA using a 320-bp PCR amplicon (region b) used as a probe after EcoRI digestion. Purified BAC
DNA was used as a positive control (þCtrl) and two founders (1 and 2) are shown. (d) Fluorescence in situ hybridization (FISH) analyses
were performed on interphase peripheral blood cells from HO-1 BAC mice using the HO-1 BAC containing DNA as a probe (right panel).
Human metaphase peripheral blood cells were used as positive control and arrows indicate the hybridization location of the HO-1 probe
labeled in SpectrumOrange on chromosome 22 band q12.3 (left panel). Negative control using the HO-1 probe on peripheral blood cells
from nontransgenic mouse (middle panel). (e) FISH analysis on HO-1 BAC transgenic bone marrow metaphase spread using the HO-1 BAC
as a FISH probe labeled in SpectrumOrange (left panel). Note the single site of integration of the HO-1 BAC into chromosome 5 band qF
(right panel).
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human and absence of mouse HO-1 in hHO-1 BAC mice
(Figure 3b). Next, the basal level of HO-1 protein expression
in HO-1þ /þ , HO-1/, and hHO-1 BAC mice were
examined in microsomal fractions from the kidney and
spleen (Figure 3c). As illustrated, HO-1 protein expression
was significantly higher in both the kidney and spleen of
hHO-1 BAC mice compared with HO-1þ /þ mice and, as
expected, no HO-1 expression was detected in the HO-1/
samples. No significant differences were noted between HO-1
and HO-2 protein levels in the liver, lung, kidney, and spleen
isolated from the HO-1 BAC and hHO-1 BAC (Supplemen-
tary Figure S1 online).
Human HO-1 in hHO-1 BAC transgenic mice rescues the
phenotype of HO-1/ mice
As hHO-1 BAC transgenic mice express human HO-1 in the
HO-1/ mice background, it is important to determine if
the integrated human HO-1 gene could rescue the phenotype
of HO-1/ mice. The fertility and live birth rate was notably
increased when we crossed hHO-1 BAC mice compared with
HO-1/ breeding pairs from which no litters were obtained
from at least 10 to 12 breeding pairs. Spleens from age-
matched HO-1þ /þ , HO-1/, and hHO-1 BAC transgenic
mice were compared (Figure 4a and b). All HO-1/ mice
had enlarged spleens with average length of 2.3±0.4 cm. On
the contrary, spleens from hHO-1 BAC mice were within the
same range of length as the HO-1þ /þ mice (1.3±0.2 and
1.2±0.3 cm, respectively). Splenic weights were significantly
higher in HO-1/ mice, but this was also reversed in hHO-1
BAC mice (Figure 4b).
Decreased hemoglobin levels, leukocytosis, and reticulo-
cytosis noted in HO-1/ mice were reversed in hHO-1 BAC
mice, and were similar to HO-1þ /þ mice (Figure 4c).
Additionally, the hHO-1 BAC hematocrit was restored to
normal levels (HO-1þ /þ : 44±0.7%, HO-1/: 32.5±2.5%,
and hHO-1 BAC: 41±0.5%, Po0.05 for HO-1þ /þ and
hHO-1 BAC vs. HO-1/). Kidneys of HO-1/ mice
showed increased iron deposition as previously described,5,37
whereas iron was barely detected in tissues from HO-1þ /þ
and hHO-1 BAC transgenic mice (Figure 4d). When com-
pared with peripheral smears of HO-1þ /þ mice, HO-1/
mice showed hypochromic microcytic anemia with consider-
able anisocytosis and fragmented red blood cells (RBCs;
Figure 4e). However, the smears of hHO-1 BAC transgenic
mice showed near-normal restoration of RBC morphology.
Interestingly, RBCs from HO-1/ and hHO-1 BAC mice
displayed inclusions that mimicked Howell–Jolly bodies.
These were also detected in peripheral smears of HO-1 BAC
transgenic mice. The number of these inclusions in the peri-
pheral smears of hHO-1 BAC mice was 1.54 per 100 RBCs
compared with 0.1% in HO-1þ /þ mice and 0.4% in HO-1/
mice.
We have recently reported that the proportion of splenic
CD8þ dendritic cells (DCs) was significantly decreased in
HO-1/ mice.38 To determine whether the human HO-1
gene product in hHO-1 BAC mice could alter this phenotype,
flow cytometry analysis of splenocytes from HO-1þ /þ ,
HO-1/, and hHO-1 BAC mice was performed. CD8þ DCs
in HO-1/ mice were significantly decreased compared with
HO-1þ /þ mice, but splenocytes in hHO-1 BAC mice showed
similar levels as HO-1þ /þ mice (Figure 4f and g).
Induction of rhabdomyolysis and cisplatin-induced kidney
injury in hHO-1 BAC transgenic mice
To examine the response of HO-1þ /þ and hHO-1 BAC
transgenic mice in heme-mediated renal injury, a model of
Table 1 | Primers for genotyping, 3C, ChIP-loop, and ChIP assays
Assay Name Primer sequence (50–30)
Genotyping BAC a For GCCTCTGGGCTGTAGTGG
BAC a Rev AGTCGAGGTGGGAAGATTGCTT
BAC b For CATCTATGTGGCCCTGGAGGA
BAC b Rev CCAGGGCTTTCTGGGCAAT
BAC c For GCAGACCCAAGCGGGTAAG
BAC c Rev CCACTTCCCTGTCTGCACATTTC
BAC d For GGAACAACAGTTGATGCTCTGCTTCC
BAC d Rev CGGGACCCTGTGATTGATTGCTC
Characterization of hHO-1 BAC mice Human-specific HO-1 For CATGACACCAAGGACCAGAG
Human-specific HO-1 Rev AGTGTAAGGACCCATCGGAG
Mouse-specific HO-1 For GGTGATGGCTTCCTTGTACC
Mouse-specific HO-1 Rev AGTGAGGCCCATACCAGAAG
3C and ChIP-loop F1 CTTGGGCTTGTCTTCCTTGCTGAAGAA
F2 GAAAGCAAGCCCAGACCGGCAGC
R1 CCCTTGGGAAACAAAGTCTGGCCATA
R2 GCTAGTGAGGGACAGATGCCACCAAG
Internal control For GCTAATAGAGGCTGCACGATGTTTGGA
Internal control Rev GCCTAATATCACACAGCTCACCCGG
ChIP 220 bp enhancer For ACAAGGCTGCATCTTAAAGC
220bp enhancer Rev TCTCTGCCTGGGTGTGCACC
4.5 kb For ATATGACTGCTCCTCTCCACCC
Abbreviations: 3C, chromosome conformation capture; BAC, bacterial artificial chromosome; ChIP, chromatin immunoprecipitation; For, forward; hHO-1 BAC, humanized HO-
1 BAC; HO, heme-oxygenase; Rev, reverse.
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glycerol-induced rhabdomyolysis was utilized as described
in the Materials and Methods. The HO-1 mRNA expression
was increased B23-fold at 4 h (data not shown) and B30-
fold at 8 h following glycerol injection in HO-1þ /þ kidneys
(Figure 5a). In contrast, hHO-1 BAC kidneys revealed
B5- and B14-fold increase in HO-1 mRNA expression at
4 h (data not shown) and 8 h, respectively, after glycerol
administration (Figure 5b). HO-1 protein and HO enzyme
activity showed higher basal levels in the hHO-1 BAC kidneys
compared with the HO-1þ /þ mice, and this increase was
even higher following glycerol-induced rhabdomyolysis at
16 h (Figure 5c and d). Survival rate and serum creatinine
level of each group of mice were monitored to determine the
protective effects of the human HO-1 gene in hHO-1 BAC
mice after glycerol-induced rhabdomyolysis. All HO-1/
mice died within 4 days after glycerol injection with markedly
increased serum creatinine. In all, 90% of HO-1þ /þ mice
and 100% of hHO-1 BAC mice survived for 10 days after
injection without significant changes in serum creatinine
levels, suggesting that the human HO-1 gene and product in
hHO-1 BAC mice remains functional (Figure 5e and f).
To further examine the response of HO-1þ /þ and hHO-1
BAC transgenic mice in a model of non-heme-mediated renal
injury, we tested the effects of cisplatin nephrotoxicity in
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Figure 2 |Heme oxygenase-1 (HO-1) protein and mRNA are overexpressed in the organs of HO-1 bacterial artificial chromosome
(BAC) transgenic mice. (a) Average body weights of HO-1 BAC mice (n¼ 5, solid square) and HO-1þ /þ mice (n¼ 4, open diamond) that
were monitored for 19 months. (b) Total RNA was isolated from indicated organs and HO-1 mRNA expression level was quantified using
real-time PCR. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used to normalize HO-1 mRNA levels. Results are shown as fold
increase versus HO-1þ /þ from three independent experiments performed in triplicate each time (mean±s.e.m.). *Po0.01. (c) HO enzyme
activity in the indicated organs of HO-1þ /þ and HO-1 BAC transgenic mice was compared. Results are shown as fold increase versus
HO-1þ /þ from three independent experiments performed (mean±s.e.m.). *Po0.05. (d) Indicated tissues were harvested and HO-1 protein
expression was determined by western analysis. Anti-GAPDH antibody was used as a loading control. (e) HO-1 expression was determined
by immunohistochemistry using HO-1 antibody (SPA-896, Stressgen) in the brain, heart, lung, liver, spleen, and kidney tissues from
HO-1þ /þ and HO-1 BAC transgenic mice. (f) Localization of HO-1 protein was determined by staining with lotus lectin (proximal tubule
marker) and HO-1 on serial sections of kidneys from HO-1 BAC transgenic mice. Arrows indicate colocalization of HO-1 and lotus lectin in
proximal tubules.
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these mice. We have previously reported that HO-1 is
induced in this model and is a protective response.12 As
expected, HO-1 mRNA and protein and enzyme activity were
increased in HO-1þ /þ mice after cisplatin administration
(Supplementary Figure S2A, C and D online). hHO-1 BAC
mice displayed significant increases in HO-1 mRNA (B3.5-
fold at 6 h; Supplementary Figure S2B online), HO-1 protein
(B2.2-fold at 12 h; Supplementary Figure S2C online), and
HO enzyme activity (B2.2-fold at 24 h; Supplementary
Figure S2E online) compared with basal levels. These data
demonstrate that even though basal levels of HO-1 are
elevated in the hHO-1 BAC mice, HO-1 is significantly
inducible in another disease setting (for example, cisplatin
nephrotoxicity), consistent with the rhabdomyolysis model.
In addition, renal function measured by serum creatinine was
markedly preserved in the hHO-1 BAC mice compared with
HO-1þ /þ mice following cisplatin administration (Supple-
mentary Figure S2F online).
Molecular mechanisms of the human HO-1 gene transcription
in vivo
We have previously shown the importance of USF1/2 and Sp1
in regulating hemin-mediated HO-1 expression in renal
epithelial cells in vitro.33,35,36 To examine the in vivo relevance
of the in vitro findings, we performed chromatin immuno-
precipitation (ChIP) assay to determine the association of the
indicated transcription factors with regulatory regions in the
HO-1 gene in kidneys of the hHO-1 BAC transgenic mice
subjected to rhabdomyolysis (Figure 6). Upon induction of
HO-1, JunB, Sp1, USF1, and USF2 were associated with
the 4.5 kb promoter region that contains the DNase I
hypersensitive site (HS), HS-2.35 However, JunD did not
show any association to the promoter region (Figure 6a). For
the 220-bp intronic enhancer region, maximal binding was
observed with Sp1, to a lesser extent with JunB, USF1, and
USF2, and no binding with JunD (Figure 6b). The þ 2.2 kb
region of the human HO-1 gene was used as a negative
control and none of the tested transcription factors were
associated with this region (Figure 6c).
CCCTC-binding factor (CTCF) is a multifunctional
transcription factor that is a master controller of several
genes by regulating activation, repression, insulation, and
silencing.39–44 Interestingly, one of the major mechanisms of
CTCF-mediated transcriptional regulation is the formation
of chromatin looping.41,45 We tested if CTCF was bound to
various regulatory regions in the kidneys of hHO-1 BAC
mice following rhabdomyolysis. ChIP assay showed that
CTCF associates with the proximal E-box, 4.5 kb promoter,
and 220 bp intronic enhancer but not the þ 2.2 kb region
upon induction of the human HO-1 gene in vivo (Figure 6d).
In vivo chromatin looping occurs in hHO-1 BAC mice for
induction of human HO-1 gene transcription
Chromatin looping was studied in hHO-1 BAC mice using
the chromosome conformation capture (3C) assay upon
induction of HO-1 transcription after glycerol-induced rha-
bdomyolysis. Mice were injected with 50% glycerol or saline
(negative control) and kidneys were removed after 3 h for
the 3C assay. BglII restriction enzyme was used to determine
the interaction of fragments containing the 220-bp enhancer
and the 4.5 kb promoter as described in the map in Figure 6e.
As shown in Figure 6f, a 7.5-fold increase of crosslinking effi-
ciency was detected between the enhancer containing fragment
with the 4.5 kb region after induction of rhabdomyolysis
compared with saline-injected mice. These results demon-
strate the pivotal role of USF1, CTCF, and Sp1 in regulating
HO-1 gene expression in vivo via chromatin looping.
USF1/2, Sp1, and CTCF regulate chromatin loop formation
Overexpression of USF1 and/or USF2 as well as Sp1 induced
endogenous HO-1 protein and mRNA in vitro. In addition,
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HO-1þ / BAC-positive mice. Primers for HO-1 BAC (a and b, see
Table 1 and Figure 1a) were used to screen whether they were
positive for HO-1 BAC. Mice were also genotyped using a
combination of primers for the detection of mouse HO-1 gene
(lower 160-bp band) and/or neomycin cassette (upper 280-bp
band) inserted in order to generate HO-1/ mice (Table 1).
(b) Genomic DNA was used to evaluate the presence of mouse
and human HO-1. Whereas the genotyping of HO-1þ /þ mice
reveals a single band at 160 bp for mouse HO-1, the absence of
mouse HO-1 in hHO-1 BAC mice gives a single band at 280 bp,
denoting the presence of the neomycin cassette derived from the
HO-1/mice. A heterozygote would reveal two bands at 160 and
280 bp. The presence of human HO-1 in hHO-1 BAC mice is
confirmed by using a human-specific primer that yields a 320-bp
band. (c) Microsomal fractions of kidney and spleen from
HO-1þ /þ , HO-1/, and hHO-1 BAC mice were isolated and
analyzed by immunoblot for HO-1 expression. The blot was stripped
and reprobed with anti-actin antibody for a loading control.
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Figure 4 |Human heme oxygenase-1 (HO-1) in hHO-1 bacterial artificial chromosome (BAC) transgenic mice rescues the
pathological phenotype of HO-1/ mice. Spleens from 25- to 35-week-old HO-1þ /þ (n¼ 8), HO-1/ (n¼ 7), and hHO-1 BAC (n¼ 7)
transgenic mice were collected and their (a) lengths and (b) weights (wt) were compared. Weights of spleen were normalized to body
weight of each animal, and average normalized values were plotted for each group (mean±s.e.m.). *Po0.05 vs. HO-1þ /þ and hHO-1 BAC
mice. (c) Whole blood from 30- to 40-week-old HO-1þ /þ , HO-1/, and hHO-1 BAC mice were collected and hemoglobin (Hgb), leukocyte
(white blood cell (WBC)), and reticulocyte counts were measured (n¼ 4–5 per group). *Po0.05 vs. HO-1þ /þ and hHO-1 BAC mice.
(d) Kidneys from 25- to 35-week-old HO-1þ /þ , HO-1/, and hHO-1 BAC mice were collected and Prussian blue staining was performed to
detect tissue iron in paraffin-embedded sections. (e) Peripheral blood smears were prepared from HO-1þ /þ , HO-1/, and hHO-1 BAC mice
and stained using Wright-Giemsa staining to determine red blood cell (RBC) morphology. (f, g) Subsets of splenic dendritic cells (DCs) from
HO-1þ /þ , HO-1/, and hHO-1 BAC transgenic mice were compared as described in the Materials and Methods. CD8 and CD4 expression is
shown on CD11c and major histocompatibility complex class II (MHC II)-gated cells from each group of mice (f). Numbers within graph
quadrants depict the percentage of CD11cþMHC IIþ -positive cells. The histogram shown depicts the average from three animals in the
percentage of CD8þ DCs among the population of CD11cþMHC IIþ DCs.
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hemin induction of HO-1 resulted in increased endogenous
Sp1 expression, but the levels of USF-1 and USF-2 were
unchanged. ChIP assays showed that USF1 associated with
the 4.5 kb HS-2, proximal E-box, and 220-bp intronic
enhancer regions upon induction of HO-1 by hemin
(Supplementary Figure S3 online). 3C assay demonstrated
that USF1 overexpression facilitated chromatin loop forma-
tion between the 4.5 kb promoter region (HS-2) and the
220-bp intronic enhancer (Supplementary Figure S4A on-
line). Similarly, the proximal E-box interacted with the
4.5 kb promoter via chromatin looping (Supplementary
Figure S4B online). Further confirmation of chromatin loop
formation was achieved using the ChIP-loop assay.46–48 Cells
were treated with 5mmol/l hemin for 3 h to induce HO-1
transcription and ChIP-loop assay was performed using the
BglII restriction enzyme along with anti-Sp1 and anti-USF-1
antibodies to precipitate crosslinked DNA–protein complex.
We demonstrate that for the interaction between the 4.5 kb
promoter (HS-2) and the 220-bp intronic enhancer, Sp1 and
USF-1 are involved in the process of chromatin looping and
subsequent HO-1 transcription (Supplementary Figure S4C
online).
In order to determine if CTCF is involved in HO-1
transcription and related with other transcription factors, we
performed ChIP assay using anti-CTCF antibody for the
proximal E-box, 4.5 kb promoter, and 220-bp intronic
enhancer regions. CTCF bound to all three regions tested
upon induction of HO-1 by hemin treatment (Supplemen-
tary Figure S5A online). Hemin-mediated HO-1 induction
caused the binding of RNA PolII to proximal E-box, 4.5 kb
promoter, and 220-bp intronic enhancer regions, but no
association was detectable with the þ 2.2 kb region that also
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Figure 5 |Heme oxygenase-1 (HO-1) expression is induced at higher levels after rhabdomyolysis in humanized HO-1 bacterial
artificial chromosome (hHO-1 BAC) mice. Rhabdomyolysis was induced by injecting 50% glycerol (7.5ml/kg body weight) in HO-1þ /þ
and hHO-1 BAC mice (a and b, respectively; n¼ 9 per group). Kidneys from HO-1þ /þ and hHO-1 BAC mice were collected and total RNA
was isolated. At 8 h after glycerol administration, HO-1 was inducedB30-fold in (a) HO-1þ /þ kidneys, whereas the (b) hHO-1 BAC kidneys
revealed B14-fold HO-1 induction. *Po0.01. (c) Microsomal fractions from kidneys of HO-1þ /þ and hHO-1 BAC mice after injection of
saline (S) as a control and 50% glycerol (G) for 16 h were analyzed for HO-1 protein expression using western analysis. Note that
normalization of the band intensity to corresponding actin levels shows no significant difference between glycerol-treated HO-1þ /þ and
hHO-1 BAC saline-treated mice. (d) Kidneys of HO-1þ /þ and hHO-1 BAC mice after injection of saline (S) and glycerol (G) were collected and
HO enzyme activity was measured at 16 h after glycerol administration as described in the Materials and Methods (n¼ 3 per group).
*Po0.05 vs. HO-1þ /þ . (e) Survival rate was monitored after induction of rhabdomyolysis in HO-1þ /þ , HO-1/, and hHO-1 BAC mice
(n¼ 10 per group). Experiments were ceased 10 days after injection. (f) Serum creatinine was measured in HO-1þ /þ , HO-1/, and hHO-1
BAC mice after indicated days after induction of rhabdomyolysis.
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contains an E-box sequence (Supplementary Figure S5A and
5B online).
DISCUSSION
In this study, we report a novel in vivo model for studying the
functional and regulatory mechanisms of the human HO-1
gene via the generation of hHO-1 BAC transgenic mice. The
integration of human HO-1 successfully rescued the
phenotype of the HO-1/ mice, demonstrating the integrity
and functional role of the human HO-1 transgene and its
gene product. Furthermore, the results of the current studies
using rhabdomyolysis-induced kidney injury in hHO-1 BAC
mice demonstrate the complex changes in chromatin con-
formation and loop formation in vivo, providing important
insights to the molecular regulation of human HO-1 gene
expression. The studies have also identified for the first time,
the involvement of CTCF, a master regulator in HO-1 gene
expression in vitro and in vivo.
HO-1 mitigates cellular injury by exerting anti-oxidant,
anti-apoptotic, and anti-inflammatory effects.31,49–51 Because
of the beneficial and protective effects of HO-1 in several
pathological states, developing an appropriate in vivo
model for the study of the molecular mechanism of HO-1
expression is imperative. Unlike other currently available in
vivo models to study the biological aspects of human HO-1,
HO-1 BAC transgenic mice can be used to study the intricate
molecular mechanisms that control human HO-1 gene
transcription. HO-1 BAC mice showed global HO-1 mRNA
and protein overexpression in multiple tissues. Interestingly,
the pattern of expression closely mimicked the sites where
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Figure 6 |Glycerol-induced rhabdomyolysis induces chromatin-looping-mediated promoter-enhancer interaction and increases
binding of JunB, Sp1, USF1/2, and CTCF to regulatory regions of the human heme oxygenase-1 (HO-1) gene in vivo.
(a–c) hHO-1 BAC transgenic mice were injected with 7.5ml/kg body wt 50% glycerol (G) or saline (S) and kidneys were harvested after 3 h.
An in vivo ChIP assay was performed to determine changes in association of indicated transcription factors within the (a) 4.5 kb human
HO-1 promoter region , (b) 220-bp intronic enhancer region, and (c) the þ 2.2 kb internal E-box region as a negative control as described in
the Materials and Methods. Results represent three independent experiments and fold enrichment vs. saline-injected mice are shown
(mean±s.e.m.). (d) Kidneys from hHO-1 BAC transgenic mice injected with 50% glycerol or saline were harvested and in vivo ChIP was
performed to determine the association of CTCF with 4.5 kb promoter, 220-bp enhancer, and proximal E-box regions. The þ 2.2 kb E-box
region was used as negative control. Results represent two independent experiments and relative fold enrichments vs. saline-injected mice
are shown (mean±s.e.m.). *Po0.05 vs. saline-treated hHO-1 BAC mice. (e) Map of the human HO-1 promoter, where B denotes BglII
restriction sites flanking the 4.5 kb promoter regions, proximal E-box elements, and 220-bp enhancer (E). Arrows denote primers used for
3C assay. Gray rectangles indicate exons in the human HO-1 gene. (f) hHO-1 BAC mice were injected with glycerol (G) and saline (S) for 3 h
and kidneys were harvested. 3C assay was performed to determine the interaction between 4.5 kb promoter and 220-bp enhancer (F2/R2)
using BglII restriction enzyme. Interactions between promoter and enhancer regions were determined and quantified as relative crosslinking
efficiency. Results shown are from three independent experiments (mean±s.e.m.). *Po0.05 vs. saline-injected hHO-1 BAC mice. 3C,
chromosome conformation capture; BAC, bacterial artificial chromosome; ChIP, chromatin immunoprecipitation; CTCF, CCCTC-binding
factor; hHO-1 BAC, humanized HO-1 BAC; HS-2, hypersensitive site 2; Sp1, specificity protein 1; USF1 and 2, upstream stimulatory factors
1 and 2.
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HO-1 would otherwise be inducible following tissue injury.
In the kidney, HO-1 expression was seen in the proximal
tubules, a site where HO-1 is induced in models of acute
kidney injury.52 In the liver, HO-1 expression was detected in
Kupffer cells. Consistent with this observation is the finding
that Kupffer cell–depleted mice fail to show resection-induced
increase of HO-1, suggesting that the major hepatic cell type
that accounts for HO-1 expression in liver is the Kupffer
cell.53,54 In the brain, astrocytes were the predominant cell
type with increased HO-1 expression in the HO-1 BAC mice.
Hypoxia-induced HO-1 expression in the brain results in
increased HO-1 levels in astrocytes, but not in the
microglia.55 Our results also demonstrate that increases in
HO enzyme activity confirm the global overexpression and
active nature of the inserted HO-1 gene in the BAC mice.
In addition, the body weight and lifespan of HO-1 BAC
mice and HO-1þ /þ did not show any major differences,
indicating that the integrated human HO-1 gene did not
cause any significant physiological derangements in the
transgenic mice.
More importantly, we demonstrate that the inserted
human HO-1 gene is functional and rescues the pathological
phenotype of the HO-1/ mice. HO-1/ mice have
reduced live births and partial embryonic lethality, which
were reversed in the hHO-1 BAC mice. Splenomegaly,
anemia, DC abnormalities, and tissue iron deposition seen
in HO-1/ mice were normalized in the hHO-1 BAC mice.
HO-1/ mice are highly sensitive to rhabdomyolysis-
induced acute kidney injury,17 and hHO-1 BAC mice showed
markedly improved survival and preserved renal function.
hHO-1 BAC mice were also protected in a model of cisplatin-
induced nephrotoxicity. Interestingly, RBCs of the HO-1 BAC
and the hHO-1 BAC mice contained increased number of
inclusions that appeared similar to Howell–Jolly bodies.
Despite the fact that Howell–Jolly bodies are generally
considered a hallmark of asplenia, the physical appearance
of the spleens of hHO-1 BAC mice as well as their
weights were not significantly different from the HO-1þ /þ
spleens. This observation is intriguing and deserves further
investigation.
Our studies using hHO-1 BAC mice support previous
in vitro evidence for chromatin looping as a mechanism for
regulation of the human HO-1 gene. Transcription factors,
Sp1, USF1/2, and JunB, were identified as positive regulators
for human HO-1 expression and our results indicate that
they are associated with the same regulatory regions and
involved in chromatin looping. These studies have also
identified a pivotal role for the transcription factor, CTCF,
in the regulation of human HO-1 gene expression. Sp1 is a
transcription factor that plays an important role in the
regulation of a number of genes. It has a zinc-finger protein
motif by which it may bind to DNA, enhancing the
transcription of the specific gene. In contrast, CTCF belongs
to a family of proteins known as chromatin insulators. These
proteins are suggested to form domains within which specific
enhancer-gene interactions may occur. Mounting evidence
suggests that CTCF may bind to distant sites or even different
chromosomes, thereby allowing chromatin looping and
transcriptional regulation.
The hHO-1 BAC transgenic mice are invaluable in vivo
models for studying not only the function but also the
regulation of the human HO-1 gene. hHO-1 BAC mice can
be used to better understand how the human HO-1 gene is
induced and protects against various disease states such as
acute kidney injury, atherosclerosis, sepsis, vascular rest-
enosis, organ transplantation, as well as others. Moreover, for
the study of transcriptional regulation of human HO-1 gene,
the hHO-1 BAC mouse containing the complete human
HO-1 gene with all its regulatory elements would be a
prerequisite for better elucidation of the mechanisms under-
lying HO-1 gene expression. Additionally, the absence of the
mouse HO-1 gene in hHO-1 BAC mice removes any
confounding effects from endogenous HO-1, allowing all
outcomes to be attributed to the human HO-1 gene. It is
important to note that the humanized HO-1 mouse
described herein depends on transcription factors that are
of murine origin. However, significant (490%) homology
exists between the transcription factors of the two species and
obviates this limitation. Another advantage of the humanized
transgenic mouse model is the potential for testing of novel
small molecular agents that could be evaluated in future
therapeutic applications.
On the other hand, we acknowledge that there are certain
limitations of this mouse model. Most importantly, the basal
levels of HO-1 are significantly higher in hBAC mice
compared with HO-1þ /þ mice. This may be because of
the insertion of the BAC DNA into the euchromatin region.
Another possible explanation is the absence of human-
specific inhibitory regulators (for example, microRNAs) in
the mouse environment. These are currently being investi-
gated in our laboratory. However, our results show that HO-
1 mRNA is significantly induced (B5-fold and 14-fold at 4
and 8 h, respectively) in hBAC mice in the rhabdomyolysis
model. Moreover, HO-1 protein levels and HO enzyme
activity are significantly higher (B3.5-fold and B8-fold,
respectively) than control levels in the glycerol model (Figure
5d). Inducibility of HO-1 mRNA and protein and enzyme
activity was also confirmed in cisplatin-induced nephrotoxi-
city, a non-heme-dependent model of acute kidney injury
(Supplementary Figure S2 online). These results indicate that
although in the basal state hBAC mice express a higher level
of HO-1, there is still capacity for significant inducibility and
thereby allowing for investigation of the human HO-1 gene
in pathological conditions.
In summary, humanized HO-1 BAC transgenic mice are
able to rescue the phenotype of HO-1/ mice, and
transcription factors including JunB, Sp1, USF1/2, and CTCF
regulate transcription of the human HO-1 gene via
chromatin looping in vivo. The hHO-1 BAC transgenic mice
can be utilized as an in vivo model to better elucidate the
functional significance and molecular regulation of the
human HO-1 gene.
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MATERIALS AND METHODS
Reagents
Tissue culture media and supplements were obtained from
Mediatech (Manassas, VA). Rabbit or mouse polyclonal antibodies
against USF1 (SC-229), USF2 (SC-862), Sp1 (SC-14027), JunB (SC-
8051), and JunD (SC-74) were from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti HO-1 (SPA-895) and HO-2 (SPA-897)
antibody was from Stressgen (Plymouth Meeting, PA). Restriction
endonucleases for chromosome conformation capture were obtained
from New England Biolabs (Beverly, MA). Lipofectamine for transient
transfection was purchased from Invitrogen (Carlsbad, CA).
Cell culture, plasmids, and transfection
Human embryonic kidney 293 (HEK293) cells (ATCC, Manassas,
VA) were grown in Dulbecco’s modified Eagle’s medium/F12 medium
(Mediatech) supplemented with 10% fetal bovine serum, 0.1 mmol/l
nonessential amino acids, 1 mmol/l sodium pyruvate, and 1.5 mg/ml
sodium bicarbonate. Cells were grown at 37 1C in 95% air and 5% CO2.
The plasmid constructs for USF1 (psvUSF1), USF2 (psvUSF2),
and pRc/CMV566 were gifts from Dr M Sawadogo (University of
Texas at Houston, Houston, TX). The dominant-negative expression
vector for USF, hemagglutinin-tagged A-USF, was kindly provided
by Dr C Vinson (National Cancer Institute, National Institutes of
Health, Bethesda, MD). The Sp1 expression vector was kindly
provided by Kun-Sang Chang (University of Texas MD Anderson
Cancer Center, Houston, TX) and has been described elsewhere.56
HEK293 cells at a confluence of 60–70% were grown in 10 cm
tissue culture dishes and were transiently transfected with equimolar
amounts of plasmids using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Transfected cells were
allowed to recuperate for indicated time periods before harvesting.
Generation of HO-1 BAC transgenic mice
The HO-1 BAC clone (GenBank accession number: Z82244;
87,869 bp) containing the human HO-1 gene along with the 30
end of the TOM1 gene and the MCM5 gene was obtained from
Sanger Institute (Cambridge, UK). The HO-1 BAC was purified for
injection using the QIAGEN Large-construct kit (QIAGEN,
Valencia, CA). The BAC was quantified using agarose gel
electrophoresis, and sets of 200 C57BL6/J oocytes were micro-
injected with 30 ng of the purified BAC DNA at the UAB Transgenic
Mouse Core facility. Fertilized ova were subsequently implanted into
pseudopregnant females and offspring were analyzed for the
insertion of the HO-1 BAC. Two independent founder lines were
produced that transmitted the transgene and genotyped with DNA
extracted from tails, followed by subsequent PCR amplification of
four different regions within the HO-1 BAC (Figure 1a) using
primers shown in Table 1. Integration of HO-1 BAC was demon-
strated by Southern blot analysis after digestion of tail DNA with
EcoRI and hybridization with the probe generated from PCR
amplicon (primer pair b), which resulted in a single band at 8 kb
(Figure 1c). The inserted BAC DNA contains the entire human
HO-1 gene along with all of its regulatory regions. Hence, all
experiments that involved hHO-1 BAC mice examine the full-length
human HO-1 gene. All animal studies were approved by our
institutional animal care and use committee.
Copy number estimation of transgenic mice
Copy number estimates were derived from DCt values for standard
curve samples that mimic the genetic integration of the transgene.
Serially diluted purified HO-1 BAC DNA were mixed with 200 ng of
mouse genomic DNA and used as standards. In order to calculate
DCt values, the average of duplicate Ct values generated with the
HO-1 BAC probe (Table 1) was subtracted from the average Ct value
of mouse prolactin (Prl) gene, which represents two copies. Then,
DCt values from genomic DNA of transgenic mice were calculated using
BAC and Prl probes as in standard samples. DDCt values were calculated
by comparing two DCt values and copy number was calculated.
Conventional cytogenetic and FISH analyses
The HO-1 BAC was labeled in SpectrumOrange using the Abbott
nick translation kit (Abbott Molecular, Des Plaines, IL) and used as
a FISH probe. The probe was validated by metaphase FISH analysis
on 20 human metaphase peripheral blood cells to confirm that it
hybridizes to chromosome 22 band q12.3 (HMOX1 gene) with no
cross-hybridization elsewhere in the human genome (Figure 1d, left
panel). Interphase FISH analyses were then performed on peripheral
blood cells from both the wild type (non-transgenic; Figure 1d,
middle panel) and transgenic mice using the HO-1 probe (Figure
1d, right panel). Slide hybridization and washes were performed
using standard FISH protocols. The slides were then counterstained
with 4,6-diamidino-2-phenylindole and analyzed with an Olympus
BX61 microscope (Olympus America, Melville, NY) equipped with
the appropriate filter combination and a CCD camera, and coupled
to the CytoVision image analysis system (Applied Imaging, Santa
Clara, CA). A total of 100 interphase cells were analyzed from each
mouse. G-banded chromosome analysis was performed on meta-
phase spreads prepared from unstimulated bone marrow cell
cultures from the transgenic mice using standard techniques. The
chromosomes were analyzed and karyotyped using the CytoVision
image analysis system (Applied Imaging).
Real-time PCR
Total RNA was isolated from cells or tissues by TRIzol (Invitrogen),
and SYBR Green-based real-time PCR was performed on cDNA
first-strand synthesis products generated from total RNA (Invitro-
gen). The reactions were performed in triplicate. Relative mRNA
expression was quantified using the DDCt method and GAPDH
(glyceraldehyde 3-phosphate dehydrogenase) was used as an internal
control. Real-time primers are described in Table 1. For copy
number estimation of transgenic mice, custom TaqMan probe for
BAC and Prl gene (control) were used. The primers for BAC were
same as the primers used for genotyping of transgenic mice (BAC b,
c, and d; Table 1) and sequences of Prl primers and probes are listed
in Table 1.
Western blot analysis
Harvested cells or collected tissues were lysed in RIPA buffer
(50 mmol/l Tris/HCl, 1% NP-40, 0.25%. deoxycholic acid,
150 mmol/l NaCl, 1 mmol/l EGTA, 1 mmol/l sodium orthovanadate,
and 1 mmol/l sodium fluoride) with protease inhibitor (Roche
Applied Science, Indianapolis, IN) and quantified using BCA
protein assay (Thermo Scientific, Rockford, IL). Total protein
(10–15 mg) was resolved on a 12% Tris-glycine sodium dodecyl
sulfate polyacrylamide gel electrophoresis. After transfer to a poly-
vinylidene fluoride membrane (Millipore, Billerica, MA), HO-1,
HO-2, and actin were detected using 1:5000 dilutions of primary
rabbit polyclonal antibodies, followed by a horseradish peroxida-
se–conjugated anti-rabbit IgG. The antibody used to detect HO-1 is
a polyclonal antibody that recognizes HO-1 of both species with the
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same intensity. Protein was visualized using the enhanced chemi-
luminescence detection system (GE Healthcare, Piscatway, NJ).
Measurement of HO enzyme activity
Tissue was homogenized in 3 ml of buffer (200 mmol/l KH2PO4,
135 mmol/l KCl, 0.1 mmol/l. EDTA, pH 7.4), and then sonicated
three times for 5 s at 4 1C. The samples were centrifuged (10,000 g,
4 1C, 20 min). The supernatant was transferred to ultracentrifuge
tubes, followed by an ultracentrifugation (100,000 g, 4 1C, 60 min;
Beckman L7–35 Ultracentrifuge, 70 Ti rotor, Indianapolis, IN).
The microsomal pellet was resuspended in 320ml of HO enzyme
activity buffer (100 mmol/l KH2PO4, 2 mmol/l MgCl2, pH 7.4).
After sonication (three times for 5 s each at 4 1C), the supernatant
was used to determine HO enzyme activity in a reaction mixture
containing rat liver cytosol (as a source of biliverdin reductase, 2 mg/
assay), hemin (20mmol/l), glucose-6-phosphate (2 mmol/l), glu-
cose-6-phosphate dehydrogenase (0.2 U), and nicotinamide adenine
dinucleotide phosphate (0.8 mmol/l) in a total volume of 400ml.
After the reaction was incubated at 37 1C for 60 min in the dark, the
formed bilirubin was extracted with 1 ml of chloroform by vigorous
vortexing three times for 10 s. After centrifugation (1000 g, 5 min,
room temperature), optical density at 464 and 530 nm of the organic
phase was determined and HO enzyme activity was calculated and
expressed as fold increase versus controls.
Immunohistochemistry
Tissues were removed and fixed in 10% formalin for 24 h and
dehydrated in 70% ethanol before embedding in paraffin. Paraffin-
embedded tissues were cut into 4mm sections, and then depar-
affinized and rehydrated using Citrisolv (d-limonene-based solvent)
and isopropanol, respectively. Retrieval of antigen for anti-HO-1
was performed by steaming in Trilogy solution. Sections were
blocked with 5% normal goat serum for 20 min, and then incubated
for 16 h at 4 1C with polyclonal rabbit anti-HO-1 antibody (SPA-
896, Stressgen) diluted 1:1000 in phosphate-buffered saline (PBS)
with 0.1% Tween-20. Peroxidase-conjugated goat anti-rabbit anti-
body was applied for 1 h at room temperature, followed by PBS
washes. VIP substrate kit (Vector Laboratories, Burlingame, CA) was
prepared following the manufacturer’s protocol and applied for
3 min. Tissues were dehydrated using ethanol and xylene and
mounted. For the study of HO-1 expression pattern in kidney, serial
paraffin-embedded tissue sections were incubated with biotinylated
lotus lectin (Vector Laboratories) or anti-HO-1 as described
earlier.57 Images were captured using a Leica DM IRB microscope
(Leica Microsystems, Bannockburn, IL) and Image-Pro Plus soft-
ware (Media Cybernetics, Bethesda, MD).
Splenic DC preparation
Spleens from HO-1þ /þ , HO-1/, and hHO-1 BAC mice were
harvested, cut into small fragments, minced, and digested with
100 U/ml collagenase D (Roche Diagnostics, Indianapolis, IN)
containing Dulbecco’s PBS (Invitrogen, Grand Island, NY) solution
and incubated for 20 min at room temperature. EDTA was added
(final concentration, 0.1 mol/l) to disrupt DC/T cell complexes and
incubated for 5 min. Cells were filtered through a 70-mm stainless
still sieve (BD Falcon; BD Biosciences, Bedford, MA) for removing
undigested fibrogenous materials and centrifuged at 300 g for
10 min. Supernatants were removed, and RBCs were lysed using
buffered ammonium chloride lysis solution. After cells were washed
in PBS, they were used for experiments.
Flow cytometry
Cells were washed once with cold PBS and were incubated for 10 min
at room temperature with anti-mouse CD16/32 (eBioscience, San
Diego, CA) to block nonspecific binding to FCg3 receptors. Cells
were initially stained with fluorescein isothicyanate–conjugated anti-
mouse CD86 (clone GL-1), phycoerythrin-conjugated anti-mouse
CD19 (clone 1D3), anti-mouse CD11c biotin (clone HL3), and
allophycocyanin-conjugated anti-mouse major histocompatibility
complex class II (MHC II) (clone M5/114.15.2) for 30 min on ice.
Cells were washed and stained with peridinin chlorophyll protein
complexconjugated anti-mouse streptavidin for additional 30 min
on ice. Phycoerythrin-conjugated, fluorescein isothicyanate–conju-
gated, and allophycocyanin-conjugated isotype-matched antobodies
of irrelevant specificity were used as controls. DC subsets were
identified by incubation with fluorescein isothicyanate–conjugated,
phycoerythrin-conjugated, peridinin chlorophyll protein complex-
conjugated, and allophycocyanin-conjugated monoclonal antibody
specific for CD11c, CD4, CD8, and MHC II, respectively. Data
acquisition was performed on a FACSCalibur flow cytometer (BD
Biosciences), and results were analyzed using Winlist Software
(Verity Software House, Topsham, MA).
Hematological assays
Peripheral blood smears were prepared using a drop of blood from
the mouse tail. Slides were submerged in methanol for 1 min
followed by Wright-Giemsa Fuccillo stain (Harleco, Lawrence, KA)
for 5 min as described.58 Slides were then transferred into 300 ml of
the Giemsa solution containing 80 ml Wright-Giemsa stain, 50 ml
phosphate buffer, pH 6.8, and 170 ml distilled water for 10 min.
Slides were washed in phosphate buffer (pH 6.8) for 3 min followed
by deionized water for 3 min. Slides were then dried at room
temperature and covered with cover slips using mounting medium
xylene (Fisher Scientific, Pittsburgh, PA).
For other hematologic indices, peripheral blood was collected
from anesthetized mice into Microtainer EDTA collection tubes (BD
Biosciences, Franklin Lakes, NJ). Hemoglobin concentrations were
determined after conversion to cyanmethemoglobin by lysing RBCs
in Drabkin reagent (Sigma-Aldrich, St Louis, MO), removing
insoluble RBC membranes by centrifugation, measuring the
absorbance at 540 nm on a spectrophotometer, and comparing
with hemoglobin standards. Reticulocyte counts were determined by
flow cytometry after staining with thiazole orange as described
elsewhere.59
Chromosome conformation capture
3C assay was performed according to the method described
earlier.60,61 Briefly, transiently transfected HEK293 cells were
recovered for 24 h. Cells were washed with PBS twice and 2%
formaldehyde was added to the cells for 10 min at room temperature
for crosslinking. For in vivo 3C assay, kidneys from hHO-1 BAC
transgenic mice injected with saline (control) or 50% glycerol to
induce rhabdomyolysis at 3 h after injection were collected and diced
into small pieces (between 1 and 3 mm3). Then, 1% formaldehyde
was added to the tissue for 20 min at room temperature for
crosslinking. The crosslinking was terminated by adding 2.5 mol/l
glycine to a final concentration of 0.125 mol/l for 10 min at 4 1C and
then samples were centrifuged at 100 g for 2 min. After washing,
cells or tissues were disaggregated by using Dounce homogenizer.
Crosslinked cells were washed with cold PBS and lysed for 1 h with
ice-cold lysis buffer containing 10 mmol/l Tris (pH 8.0), 10 mmol/l
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NaCl, 0.2% NP-40, and 1 mmol/l dithiothreitol. The nuclei of the
cells were then harvested and suspended in the appropriate
restriction enzyme buffer containing 0.3% SDS and incubated at
37 1C for 1 h with gentle shaking. SDS was then sequestered from the
samples by the addition of 1.8% Triton X-100 (Fisher Scientific) and
the samples were incubated at 37 1C for 1 h. The samples were
digested with either BglII or SphI restriction enzyme (New England
Biolabs) at 37 1C for 16 h. Restriction enzymes were inactivated by
the addition of 1.6% SDS and further incubation at 65 1C for
20 min. Samples were diluted with T4 DNA ligase buffer (New
England Biolabs) to achieveB3 ng of DNA/ml, then 200 U T4 DNA
ligase (New England Biolabs) was added and incubated for 4 h at
16 1C. Samples were then incubated with Triton X-100 followed by
incubation with Proteinase K (200 mg/ml) at 65 1C for 16 h to reverse
the crosslinking. This was followed by the addition of 10 mg of
RNase/ml and the DNA was purified by phenol–chloroform
extraction. Then, 300 ng of DNA was analyzed by quantitative
real-time PCR, performed with SYBR GreenER qPCR Mastermix
(Invitrogen) using primers listed in Table 1. Cycling was performed
on a Applied Biosystems Prism 7900HT Sequence Detection System
(Applied Biosystems, Foster City, CA) with the following para-
meters: 50 1C for 2 min, Taq activation at 95 1C for 10 min, then 40
cycles of 95 1C for 15 s and 60 1C for 1 min. Reactions were
performed in triplicate and specificity monitored using melting
curve analysis after cycling. Crosslinking efficiency was calculated as
described previously.33
Chromatin immunoprecipitation
In vivo ChIP assay was performed by using ChIP-IT Express kit
(Active Motif, Carlsbad, CA) according to the manufacturer’s
protocol. Briefly, kidneys from hHO-1 BAC transgenic mice were
collected and sliced into small pieces (1–3 mm3) using a razor blade
or scalpel. Then, tissues were transferred into 15 ml conical tubes
containing 10 ml fixation solution (1% formaldehyde in minimal
cell culture medium). Cells were resuspended completely and rotate
tube at room temperature for 10 min. Crosslinking was stopped by
adding 1 ml 10 Glycine Stop-Fix Solution, rotate 5 min at room
temperature. Cells were pelleted by centrifuging for 5 min at 720
RCF followed by resuspension in 1.5 ml ice-cold Lysis Buffer. After
homogenization, nuclear extract was digested with 3.3 U of
Enzymatic Shearing Cocktail for 15 min at 37 1C. The enzyme
reaction was stopped by adding EDTA and then the sheared
chromatin was collected after centrifugation for 10 min at 4 1C.
Then, 2 mg of indicated antibodies as well as IgG control were used
for pulling down in 7 mg of sheared chromatin. After 16 h of
incubation at 4 1C, magnetic beads were washed and chromatin was
eluted by adding Reverse Crosslink Buffer. Quantitative real-time
PCR was used for analysis as described earlier.33
Rhabdomyolysis
Glycerol model of rhabdomyolysis was induced in age-matched
hHO-1 BAC, HO-1þ /þ , and HO-1/ mice deprived of water for
16 h as described previously.62 Mice were anesthetized by isoflurane
and were injected with 50% glycerol in water or saline as a control,
7.5 ml/kg body weight, with half the volume delivered into each
anterior thigh muscle. Mice were killed 3 h after injection for the
ChIP and 3C assay and at 4 and 8 h for HO-1 mRNA and at 16 h for
HO-1 protein and enzyme activity measurements. Survival studies
were performed in additional hHO-1 BAC, HO-1þ /þ , and HO-1/
mice (n¼ 10/group).
Cisplatin injury model
HO-1þ /þ and hHO-1 BAC mice (8 to 14 weeks of age) were
administered 20 mg/kg body weight cisplatin (1.0 mg/ml solution in
sterile 0.9% NaCl) or normal saline by a single intraperitoneal
injection. All animals were killed at the indicated time points after
cisplatin administration and kidneys were harvested for HO-1
mRNA and protein and enzyme activity measurements. Blood was
collected via heart puncture and serum was isolated for creatinine
determination.
Statistical analysis
All the experiments were performed at least three times. Results are
expressed as mean±s.e.m. and are derived from three independent
experiments. Student’s t-test and analysis of variance with Student-
Newman-Keuls post-test was used for comparisons. All results are
considered significant at Po0.05.
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